<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="200188">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00484224</url>
  </required_header>
  <id_info>
    <org_study_id>qwer1234-HMO-CTIL</org_study_id>
    <nct_id>NCT00484224</nct_id>
  </id_info>
  <brief_title>Audiological Disturbances in Vitiligo</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine wether vitiligo patients have more audiological
      abmnormalities, than the healthy population.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Screening</primary_purpose>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Cross-Sectional, Prospective</time_perspective>
  </study_design_info>
  <condition>Vitiligo</condition>
  <condition>Hearing Loss</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  vitligo patients under 50. healthy patients under 50 for control group

        Exclusion Criteria:

          -  above age 50. systemic disease. exposure to loud noise in past. familial history of
             deafness use of autotoxuc drugs or steroids. autoimmune/metabolic/neurologic/vascular
             disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arieh Ingber, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arieh Ingber, Prof.</last_name>
    <phone>972 2 6776366</phone>
    <email>Arieh@hadassah.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Aydogan K, Turan OF, Onart S, Karadogan SK, Tunali S. Audiological abnormalities in patients with vitiligo. Clin Exp Dermatol. 2006 Jan;31(1):110-3.</citation>
    <PMID>16309498</PMID>
  </reference>
  <verification_date>May 2007</verification_date>
  <lastchanged_date>June 7, 2007</lastchanged_date>
  <firstreceived_date>June 7, 2007</firstreceived_date>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Vitiligo</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
